**BioMade and Lygos to Launch Multi-User Biomanufacturing Facility in Hayward**
BioMade, a Defense Department-sponsored Manufacturing Innovation Institute established in 2021, has partnered with Lygos, a sustainable specialty chemicals company, to transition Lygos’ pilot-scale infrastructure in Hayward, California, into a nationally accessible, multi-user biomanufacturing facility. Located at 25821 Industrial Blvd., the site will be independently operated by BioMade and represents the second announced location in the organization’s growing national network.
According to the San Francisco Business Times, the U.S. bioindustrial manufacturing sector faces significant challenges in scaling up due to inadequate infrastructure. This often forces domestic companies to seek manufacturing capabilities abroad.
“This facility will play a critical role as America works to regain dominance in the biotechnology and biomanufacturing industry,” said Douglas Friedman, CEO of BioMade. “Other countries around the world have been investing in biotechnology for decades, and the U.S. is at risk of falling behind. Expanding nationwide capabilities to produce chemicals and materials needed for defense and consumer applications will strengthen national security and secure domestic supply chains.”
The Hayward facility is one of twelve pilot-scale biomanufacturing sites BioMade plans to develop across the country and is the only one currently planned for California.
